Scottsdale, AZNCT07324031Now EnrollingIRB Ready

Ventricular Arrythmia Clinical Trial in Scottsdale, AZ

Access cutting-edge ventricular arrythmia treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.

Sponsored by AtaCor Medical, Inc.

Quick Self-Assessment

See if you qualify for this Scottsdale location

Preparing your pre-screening questions…

Expert Care in Scottsdale

Access ventricular arrythmia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ventricular arrythmia treatment provided free

Apply for This Scottsdale Location

Check if you qualify for this ventricular arrythmia clinical trial in Scottsdale, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Scottsdale

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Scottsdale site if eligible
  4. 4Begin participation

About This Ventricular Arrythmia Study in Scottsdale

The ALARION EV Study is a prospective, multi-center, single-arm, non-randomized study without concurrent or historical controls. The purpose of this pivotal study is to generate evidence of safety and effectiveness to apply for regulatory approvals for commercialization of the Parasternal EV-ICD System. The objective of the study is to demonstrate safety and effectiveness of the Parasternal EV-ICD System through 6-months.

Sponsor: AtaCor Medical, Inc.

Who Can Participate

Inclusion Criteria

At least 18 years old
Class I or IIa indication for implantation of an ICD according to the ACC/AHA/HRS Guidelines or ESC guidelines

Exclusion Criteria

Patients who cannot read or write
Expected survival \< 1 year
Pregnant or nursing subjects and those who plan pregnancy during the clinical investigation follow-up period
Participation in any concurrent clinical study without prior approval from the Sponsor
Inability or unwillingness to provide informed consent to participate in the study
Any known circumstances which may prevent the completion of protocol testing and data collection through the 6-month follow-up visit
Circumstances that may prevent data collection or completion of specified follow-up visits
Allergies to any device materials listed in the Instructions for Use (IFU)
Contraindication for temporary suspension of oral/systemic anticoagulation
Known history of lung disease with FEV1 \< 1.0 Liter Device Related:
Implanted with or planned implantation of any device which delivers current in the body that may interfere with therapy delivery, including, but not limited to a pacemaker, LVAD or neurostimulator
Implanted with a subcutaneous ICD lead, subcutaneous coils/arrays, epicardial patches or epicardial pace/sense leads
Any known need for MRI prior to approval of MRI conditional labeling Anatomy Related:
Known structural abnormalities of the heart that may increase risk of the Parasternal EV-ICD System procedure
Known obstructed or restricted pathway into the mediastinum for the Atala™ lead
Prior surgery with disruption of the lung, pericardium or connective tissue between the sternum and pericardium, including sternotomy of any type
Known significant anatomic derangement of or within the thorax (e.g., pectus excavatum, significant scoliosis)
History of thoracic radiation therapy or other medical treatments/conditions which may complicate the Parasternal EV-ICD System implant procedure
Known adhesions in the thorax or history of medical treatments, surgeries or conditions that increase the potential for adhesions in the thorax
Surgically corrected congenital heart disease (not including catheter-based procedures) Cardiac Related:
Indication for permanent bradycardia pacing or cardiac resynchronization therapy
Decompensated heart failure
Currently on inotropic therapy
Known history of pericardial disease, pericarditis or mediastinitis
Risk factors associated with defibrillation testing:
Severe aortic stenosis
Current Intracardiac LA or LV thrombus
Severe proximal three-vessel or left main coronary artery disease without revascularization
Hemodynamic instability
Unstable angina
Recent stroke or transient ischemic attack (within the last 3 months)
Known inadequate external defibrillation
LVEF \< 20% (most recent assessment; must be within 180 days of consent)
LVEDD \>70 mm (most recent assessment; must be within 180 days of consent)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Scottsdale?

Yes, this clinical trial (NCT07324031) has an active research site in Scottsdale, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ventricular Arrythmia Treatment Options in Scottsdale, AZ

If you're searching for ventricular arrythmia treatment options in Scottsdale, AZ, this clinical trial (NCT07324031) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ventricular arrythmia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ventricular arrythmia clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Scottsdale, AZ

See all heart attack clinical trials recruiting in Scottsdale — not just this study.

Browse Heart Attack Trials in Scottsdale →

Browse More Trials by Condition

Heart Attack TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Scottsdale?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Scottsdale, AZ